Oncology / cancer therapeutics companies
Companies whose enriched business profile is tagged “Oncology / cancer therapeutics”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + Finnhub, shown with its as-of date.
- Amgen (AMGN) Health Care — A global biotechnology innovator producing biologics, monoclonal antibodies, and small molecules across oncology, cardiovascular, inflammation, and bone health, navigating complex U.S. Medicare pricing pressures. ask →
- Revolution Medicines (RVMD) Health Care — A precision oncology biotech in clinical development stages, pursuing targeted cancer therapies with no approved products yet but backed by substantial capital. ask →
- Jazz Pharmaceuticals (JAZZ) Health Care — A rare-disease biopharmaceutical company with diversified marketed therapies in epilepsy, sleep disorders, and oncology, and an expanding pipeline of innovative treatments. ask →
- Exelixis (EXEL) Health Care — Exelixis is a profitable oncology company commercializing the multi-kinase inhibitor cabozantinib across multiple cancer indications while advancing a pipeline of next-generation small molecules and antibody-drug conjugates. ask →
- Summit Therapeutics (SMMT) Health Care — Oncology-focused biotech developing ivonescimab, a first-in-class bispecific antibody combining PD-1 immunotherapy with anti-VEGF anti-angiogenesis, with Phase III trials underway in lung and colorectal cancers. ask →
- SYNDAX PHARMACEUTICALS INC (SNDX) Health Care — Syndax is a commercial-stage biopharmaceutical company with two FDA-approved oncology drugs (REVUFORJ and NIKTIMVO) partnered with major pharma, generating rapid revenue growth from product sales and collaborations. ask →
- ORIC PHARMACEUTICALS INC (ORIC) Health Care — ORIC Pharmaceuticals is a clinical-stage oncology company developing targeted therapies for hard-to-treat cancers through precision medicine approaches. ask →
- KURA ONCOLOGY INC (KURA) Health Care ask →
- CYTOMX THERAPEUTICS INC (CTMX) Health Care — CytomX is developing conditionally activated cancer therapies using its PROBODY platform to enable selective tumor targeting with reduced systemic toxicity, starting with varsetatug masetecan for colorectal cancer. ask →
- SUTRO BIOPHARMA INC (STRO) Health Care ask →
- KARYOPHARM THERAPEUTICS INC (KPTI) Health Care — Karyopharm is a clinical-stage oncology company commercializing XPOVIO, a first-in-class XPO1 inhibitor for multiple myeloma, with ongoing trials in myelofibrosis and endometrial cancer. ask →
- WHITEHAWK THERAPEUTICS INC (WHWK) Health Care — Clinical-stage oncology company developing next-generation antibody-drug conjugates (ADCs) targeting validated tumor antigens with advanced linker-payload technology. ask →
- CORBUS PHARMACEUTICALS HOLDINGS IN (CRBP) Health Care — Clinical-stage biopharmaceutical company developing next-generation antibody drug conjugates for oncology and a CB1 receptor inverse agonist for obesity. ask →
Not quite it? Describe exactly what you want →
Data: SEC EDGAR (filings) + Finnhub (fundamentals, delayed daily-close). Figures shown with their as-of date.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.